Automatic spending cuts have hit America's science and research sectors especially hard, according to experts, who warn of potentially dire implications for the nation's overall competitiveness. As the "sequester," a package of spending cuts imposed last month, begins to pinch, many research projects will be slowed or scuttled, from cancer therapies to efforts to convert medical breakthroughs into marketable therapies.